Skip to main content
Clinical Trials/NCT01404819
NCT01404819
Completed
Not Applicable

Evaluation of Brain Damage Resulting From Carotid Endarterectomy With Xenon Anesthesia

Centre Hospitalier Universitaire de Nīmes1 site in 1 country86 target enrollmentApril 2012

Overview

Phase
Not Applicable
Intervention
Anesthesia with Xenon
Conditions
Carotid Endarterectomy
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
86
Locations
1
Primary Endpoint
Presence/absence of S100B > 0.2 ng/ml during surgery
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The objective of this study is to show that, in patients undergoing carotid endarterectomy, brain damage, assessed by the determination of S100B before removing the clamp, is less severe with a balanced anesthesia consisting of remifentanil combined with Xenon (experimental arm) compared with remifentanil anesthesia associated with propofol (reference arm).

Registry
clinicaltrials.gov
Start Date
April 2012
End Date
February 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • Patients with American Society of Anesthesiology (ASA) scores of 1 to 4
  • Patient schelduled for carotid endarterectomy

Exclusion Criteria

  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient is pregnant
  • The patient is breastfeeding
  • The patient has a contra-indication for a treatment necessary for this study
  • The endarterectomy does not require a shunt
  • ASA score of 5

Arms & Interventions

Experimental arm

Patients in this arm undergo anesthesia with Xenon.

Intervention: Anesthesia with Xenon

Standard arm

Patients in this arm undergo standard anesthesia

Intervention: Standard anesthesia

Outcomes

Primary Outcomes

Presence/absence of S100B > 0.2 ng/ml during surgery

Time Frame: During surgery (expected mean time of around 120 minutes)

Presence/absence of S100 calcium binding protein B concentration after induction and before the removal of the radial arterial catheter clamp placed before induction

Secondary Outcomes

  • S100B change relative to baseline(end of surgery (expected mean of 120 minutes))
  • NSE change from baseline(end of surgery (expected mean of 2 hours))
  • Change in troponine from baseline(end of surgery (expected mean of 2 hours))
  • Change in creatinemia from baseline(end of surgery (expected mean of 2 hours))
  • Change in creatine clearance from baseline(end of surgery (expected mean of 2 hours))
  • Change NIHSS score from baseline(end of surgery (expected mean of 2 hours))
  • Number of transfusions(During surgery (estimated mean of 120 minutes))
  • Direct costs(2 days)
  • Indirect costs(2 days)

Study Sites (1)

Loading locations...

Similar Trials